Home/Filings/4/0001604643-23-000083
4//SEC Filing

Grieco Vincent 4

Accession 0001604643-23-000083

CIK 0001604643other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:28 PM ET

Size

17.9 KB

Accession

0001604643-23-000083

Insider Transaction Report

Form 4
Period: 2023-05-24
Grieco Vincent
EVP, Secretary & GC
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2422,2770 total
    Exercise: $24.76Exp: 2031-02-16Common Stock (22,277 underlying)
  • Disposition to Issuer

    Common Stock

    2023-05-2497,3860 total
  • Award

    Common Stock

    2023-05-24+18,95897,386 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2434,4160 total
    Exercise: $12.67Exp: 2029-02-14Common Stock (34,416 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2425,0840 total
    Exercise: $7.42Exp: 2026-12-19Common Stock (25,084 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2433,2790 total
    Exercise: $20.88Exp: 2028-04-02Common Stock (33,279 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2428,9020 total
    Exercise: $23.63Exp: 2030-02-14Common Stock (28,902 underlying)
Footnotes (7)
  • [F1]Represents performance share units ("PSUs") that became earned (at target award level) pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023, upon effectiveness of the merger on May 24, 2023.
  • [F2]Disposed of pursuant to the merger agreement. Upon effectiveness of the merger, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") and PSUs (at target award level) were converted into RSUs relating to Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share.
  • [F3]This option is fully vested.
  • [F4]Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share.
  • [F5]Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent.
  • [F6]This option vests in four equal annual installments starting on Jan. 1, 2021.
  • [F7]This option vests in four equal annual installments starting on Feb. 16, 2022.

Issuer

Evoqua Water Technologies Corp.

CIK 0001604643

Entity typeother

Related Parties

1
  • filerCIK 0001720156

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:28 PM ET
Size
17.9 KB